Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP185704.RAihblhw-NLJAYLsxQt1OgbkCtdOX35jP4Xg9_Ngrmpv8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP185704.RAihblhw-NLJAYLsxQt1OgbkCtdOX35jP4Xg9_Ngrmpv8130_assertion type Assertion NP185704.RAihblhw-NLJAYLsxQt1OgbkCtdOX35jP4Xg9_Ngrmpv8130_head.
- NP185704.RAihblhw-NLJAYLsxQt1OgbkCtdOX35jP4Xg9_Ngrmpv8130_assertion description "[Based on the genetic analysis in a high-risk population of acute MI patients with interventional treatment and continuous clopidogrel therapy, our study found a protective effect for carriers of an increased-function CYP2C19*17 T-allele with significantly]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185704.RAihblhw-NLJAYLsxQt1OgbkCtdOX35jP4Xg9_Ngrmpv8130_provenance.
- NP185704.RAihblhw-NLJAYLsxQt1OgbkCtdOX35jP4Xg9_Ngrmpv8130_assertion evidence source_evidence_literature NP185704.RAihblhw-NLJAYLsxQt1OgbkCtdOX35jP4Xg9_Ngrmpv8130_provenance.
- NP185704.RAihblhw-NLJAYLsxQt1OgbkCtdOX35jP4Xg9_Ngrmpv8130_assertion SIO_000772 20826260 NP185704.RAihblhw-NLJAYLsxQt1OgbkCtdOX35jP4Xg9_Ngrmpv8130_provenance.
- NP185704.RAihblhw-NLJAYLsxQt1OgbkCtdOX35jP4Xg9_Ngrmpv8130_assertion wasDerivedFrom gad-20150221 NP185704.RAihblhw-NLJAYLsxQt1OgbkCtdOX35jP4Xg9_Ngrmpv8130_provenance.
- NP185704.RAihblhw-NLJAYLsxQt1OgbkCtdOX35jP4Xg9_Ngrmpv8130_assertion wasGeneratedBy ECO_0000203 NP185704.RAihblhw-NLJAYLsxQt1OgbkCtdOX35jP4Xg9_Ngrmpv8130_provenance.